Kasey Thompson
Physician Assistant · Cleveland, TNNPI 1245821735
Payments from drug & device makers
Across 162 payments — averaging $23.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$695
- AstraZeneca$597
- Actelion Pharmaceuticals US, Inc.$568
- Merck$178
- Boehringer Ingelheim$164
- Takeda Pharmaceuticals U.S.A., Inc.$161
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,70997%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 26 | $695 |
| AstraZeneca | 28 | $597 |
| Actelion Pharmaceuticals US, Inc. | 7 | $568 |
| Merck | 6 | $178 |
| Boehringer Ingelheim | 10 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $161 |
| ANI Pharmaceuticals, Inc. | 7 | $147 |
| Insmed, Inc. | 6 | $141 |
| Grifols USA, LLC | 8 | $135 |
| AbbVie | 9 | $134 |
| Otsuka America Pharmaceutical, Inc. | 6 | $109 |
| Baxter Healthcare | 5 | $108 |
| Lilly USA, LLC | 8 | $106 |
| United Therapeutics Corporation | 4 | $95 |
| Novo Nordisk | 4 | $79 |
| Amgen | 2 | $56 |
| Pfizer | 2 | $40 |
| Vifor Pharma, Inc. | 1 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Sanofi | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| La Jolla Pharmaceutical Company | 1 | $25 |
| Novartis | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Philips North America LLC | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Electromed, Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,805 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UptraviSelexipag | 23 | $439,552 |
| WinrevairSotatercept-Csrk | 20 | $370,848 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 380 | $322,501 |
| OpsumitMacitentan | 14 | $173,458 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 13 | $170,951 |
| OfevNintedanib Esylate | 13 | $169,194 |
| OpsynviMacitentan/Tadalafil | 11 | $166,343 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 133 | $131,418 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 94 | $57,375 |
| Spiriva RespimatTiotropium Bromide | 56 | $44,874 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 53 | $31,491 |
| Breo ElliptaFluticasone/Vilanterol | 49 | $26,908 |
| AirsupraAlbuterol Sulfate/Budesonide | 18 | $13,281 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 315 | $11,875 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $7,191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Actelion Pharmaceuticals US, Inc.Uptravi, Opsumit, Opsynvi | $568 | $779,35248 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $695 | $380,900482 claims |
| MerckWinrevair | $178 | $370,84820 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat | $164 | $271,442163 claims |
| Grifols USA, LLCProlastin C | $135 | $170,95113 claims |
| AstraZenecaBreztri Aerosphere, Airsupra, Symbicort | $597 | $151,889172 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Cleveland
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
- Elisabeth BennettNashville$109K
- Whitney GatewoodMemphis$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.